Intentional Emotional Face Production in Children With Autism Spectrum Disorder Is Related to Social Functioning but Not Affect Recognition

2020 ◽  
Vol 74 (4_Supplement_1) ◽  
pp. 7411505199p1
Author(s):  
Sharada Krishnan ◽  
Emily Kilroy ◽  
Christiana Butera ◽  
Laura Harrison ◽  
Aditya Jayashankar ◽  
...  
2019 ◽  
Vol 8 (7) ◽  
pp. 1061 ◽  
Author(s):  
Mohamed A. Hendaus ◽  
Fatima A. Jomha ◽  
Ahmed H. Alhammadi

Autism spectrum disorder (ASD) is a developmental disability described by diagnostic criteria that comprise deficits in social communication and the existence of repetitive, restricted patterns of behavior, interests, or activities that can last throughout life. Many preclinical studies show the importance of arginine vasopressin (AVP) physiology in social functioning in several mammalian species. Currently, there is a trend to investigate more specific pharmacological agents to improve social functioning in patients with ASD. Neurobiological systems that are crucial for social functioning are the most encouraging conceivable signaling pathways for ASD therapeutic discovery. The AVP signaling pathway is one of the most promising. The purpose of this commentary is to detail the evidence on the use of AVP as an agent that can improve social functioning. The pharmacologic aspects of the drug as well as its potential to ameliorate social functioning characteristics in human and animal studies are described in this manuscript. AVP, especially in its inhaled form, seems to be safe and beneficial in improving social functioning including in children with autism. Larger randomized studies are required to implement a long awaited safe and feasible treatment in people with a deficiency in social functioning.


2017 ◽  
Vol 33 ◽  
pp. 21-28 ◽  
Author(s):  
Amir Hossein Memari ◽  
Fatemeh Sadat Mirfazeli ◽  
Ramin Kordi ◽  
Monir Shayestehfar ◽  
Pouria Moshayedi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document